Health
Kolkata/Mumbai, July 19 (Just Earth News): Sanofi-Synthelabo (India) Private Limited announced the launch of two drugs for type 2 diabetes patients in India: Lyxumia (lixisenatide) and Zemiglo (gemigliptin), an official release said. more